Mar 28 |
Better Cathie Wood Stock: Moderna vs. Intellia
|
Mar 22 |
Intellia opts out of hemophilia pact with Regeneron
|
Mar 21 |
Hot Stocks: The 3 Best Opportunities for Investing in Biotech
|
Mar 21 |
3 Stocks That Could Be the Next Big Thing in Gene Editing
|
Mar 19 |
Intellia (NTLA) Begins Dosing in Phase III ATTR Amyloidosis Study
|
Mar 18 |
Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy
|
Mar 9 |
Is Intellia Therapeutics Stock a Buy Now?
|
Mar 6 |
Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst
|
Feb 29 |
Intellia Therapeutics Is On The Move
|
Feb 29 |
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now
|